Skip to content
Skip to navigation menu

Cymraeg

RSS

Research

10 Apr 2014

Developing new anti-cancer medicines

 Professor Chris McGuigan

The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.

ProTide is a platform developed by Professor Chris McGuigan and his team at Cardiff University’s School of Pharmacy and Pharmaceutical Sciences. ProTides are specifically designed to bypass key cancer cell resistance pathways that limit the efficacy of so many of today’s anti-cancer drugs.

Read more

First direct evidence of cosmic inflation First direct evidence of cosmic inflation

17/03/2014

Cardiff physicists part of international team

GW4 Building Communities Fund launched GW4 Building Communities Fund launched

07/03/2014

New GW4 research fund to tackle world’s ‘grand challenges’

Global hunt for Alzheimer’s risk genes looks for clues in early-onset sufferers Global hunt for Alzheimer’s risk genes looks for clues in early-onset sufferers

21/02/2014

Largest project of its kind gets £388k funding boost from Alzheimer’s Research UK with support from Iceland Foods

Latest News

The European Cancer Stem Cell Research Institute
Neuroscience & Mental Health Research Institute
Sustainable Places Research Institute
Cardiff Catalysis Insititute Advert
Cardiff University on Futurity